These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 31046793)

  • 21. Protective immunity conferred by porcine circovirus 2 ORF2-based DNA vaccine in mice.
    Sylla S; Cong YL; Sun YX; Yang GL; Ding XM; Yang ZQ; Zhou YL; Yang M; Wang CF; Ding Z
    Microbiol Immunol; 2014 Jul; 58(7):398-408. PubMed ID: 24845706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular and humoral immunity following vaccination with two different PCV2 vaccines (containing PCV2a or PCV2a/PCV2b) and challenge with virulent PCV2d.
    Venegas-Vargas C; Taylor LP; Foss DL; Godbee TK; Philip R; Bandrick M
    Vaccine; 2021 Sep; 39(39):5615-5625. PubMed ID: 34420789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimized production of full-length PCV2d virus-like particles in Escherichia coli: A cost-effective and high-yield approach for potential vaccine antigen development.
    Zhang C; He F; Li N; Du W; Wen J; Wu X; Shi J; Li C; Liu C; Xu S; Han H; Hrabchenko N; Han X; Li J
    Microb Pathog; 2024 May; 190():106630. PubMed ID: 38556102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune responses of piglets immunized by a recombinant plasmid containing porcine circovirus type 2 and porcine interleukin-18 genes.
    Chen GL; Fu PF; Wang LQ; Li XS; Chen HY
    Viral Immunol; 2014 Dec; 27(10):521-8. PubMed ID: 25268976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective efficacy of a virus-vectored multi-component vaccine against porcine reproductive and respiratory syndrome virus, porcine circovirus type 2 and swine influenza virus.
    Tian D; Sooryanarain H; Matzinger SR; Gauger PC; Karuppannan AK; Elankumaran S; Opriessnig T; Meng XJ
    J Gen Virol; 2017 Dec; 98(12):3026-3036. PubMed ID: 29091579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative immunogenic and immunoprotective activities of PCV2d Cap and Rep antigens delivered by an efficient eukaryotic expression system engineered into a Salmonella vaccine vector.
    Lloren KKS; Sivasankar C; Lee JH
    Vet Microbiol; 2024 Aug; 295():110151. PubMed ID: 38870752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A commercial PCV2a-based vaccine is effective in protection from experimental challenge of PCV2 mutant with two amino acids elongation in capsid protein.
    Guo LJ; Fu YJ; Huang LP; Wang YP; Wei YW; Wu HL; Liu CM
    Vaccine; 2015 Jul; 33(31):3752-7. PubMed ID: 26051516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs.
    Fenaux M; Opriessnig T; Halbur PG; Elvinger F; Meng XJ
    J Virol; 2004 Jun; 78(12):6297-303. PubMed ID: 15163723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Commercial PCV2a-based vaccines are effective in protecting naturally PCV2b-infected finisher pigs against experimental challenge with a 2012 mutant PCV2.
    Opriessnig T; Gerber PF; Xiao CT; Halbur PG; Matzinger SR; Meng XJ
    Vaccine; 2014 Jul; 32(34):4342-8. PubMed ID: 24929119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and phylogenetic analysis of the current porcine circovirus 2 genotypes after implementation of widespread vaccination programmes in the USA.
    Shen HG; Halbur PG; Opriessnig T
    J Gen Virol; 2012 Jun; 93(Pt 6):1345-1355. PubMed ID: 22398315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of novel recombinant porcine circovirus type 2d (PCV2d) vaccine in pigs naturally infected with PCV2d.
    Kim K; Hahn TW
    Vaccine; 2021 Jan; 39(3):529-535. PubMed ID: 33342633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective efficacy of a DNA vaccine encoding capsid protein of porcine circovirus-like virus P1 against porcine circovirus 2 in mice.
    Zhang D; He K; Wen L; Fan H
    Microbiol Immunol; 2018 Mar; 62(3):195-199. PubMed ID: 29315776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel chimeric porcine circovirus (PCV) with the capsid gene of the emerging PCV2b subtype cloned in the genomic backbone of the non-pathogenic PCV1 is attenuated in vivo and induces protective and cross-protective immunity against PCV2b and PCV2a subtypes in pigs.
    Beach NM; Ramamoorthy S; Opriessnig T; Wu SQ; Meng XJ
    Vaccine; 2010 Dec; 29(2):221-32. PubMed ID: 21044670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation and immunogenicity of a recombinant pseudorabies virus expressing cap protein of porcine circovirus type 2.
    Song Y; Jin M; Zhang S; Xu X; Xiao S; Cao S; Chen H
    Vet Microbiol; 2007 Jan; 119(2-4):97-104. PubMed ID: 17005335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic analysis of porcine circovirus type 2 (PCV2) strains between 2002 and 2016 reveals PCV2 mutant predominating in porcine population in Guangxi, China.
    Yao J; Qin Y; Zeng Y; Ouyang K; Chen Y; Huang W; Wei Z
    BMC Vet Res; 2019 Apr; 15(1):118. PubMed ID: 31023307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective humoral immunity in guinea pigs induced by PCV2 virus-like particles displaying the B cell linear epitope (
    Wang N; Zhang S; Wang D; Li F; Liang L; Li X; Zou Y; Zhan Y; Chen G; Yu W; Deng Z; Tu D; Cui S
    Vet Microbiol; 2019 Aug; 235():86-92. PubMed ID: 31282383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A live-attenuated chimeric porcine circovirus type 2 (PCV2) vaccine is transmitted to contact pigs but is not upregulated by concurrent infection with porcine parvovirus (PPV) and porcine reproductive and respiratory syndrome virus (PRRSV) and is efficacious in a PCV2b-PRRSV-PPV challenge model.
    Opriessnig T; Shen HG; Pal N; Ramamoorthy S; Huang YW; Lager KM; Beach NM; Halbur PG; Meng XJ
    Clin Vaccine Immunol; 2011 Aug; 18(8):1261-8. PubMed ID: 21653745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity of porcine circovirus type 2 capsid protein targeting to different subcellular compartments.
    Fan H; Xiao S; Tong T; Wang S; Xie L; Jiang Y; Chen H; Fang L
    Mol Immunol; 2008 Feb; 45(3):653-60. PubMed ID: 17709139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral application of freeze-dried yeast particles expressing the PCV2b Cap protein on their surface induce protection to subsequent PCV2b challenge in vivo.
    Patterson R; Eley T; Browne C; Martineau HM; Werling D
    Vaccine; 2015 Nov; 33(46):6199-205. PubMed ID: 26476879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy comparison of commercial porcine circovirus type 2 (PCV2) and
    Yang S; Park SJ; Oh T; Cho H; Chae C
    Can J Vet Res; 2020 Oct; 84(4):272-282. PubMed ID: 33012976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.